Carl Gordon

Carl Gordon

Net worth: 59 063 $ as of 31/05/2026

61 year
Health Technology
Finance
Commercial Services

Profile

Carl Lee Gordon founded OrbiMed Advisors LLC in 1989, where he is working as Managing Partner from 2018.
Dr. Gordon also currently works at Compass Therapeutics, Inc., as Chairman from 2019, Sapphire Therapeutics, Inc., as Director, Amnis Corp., as Director from 2008, and various other companies.
Dr. Gordon also formerly worked at MBX Biosciences, Inc., as Independent Director from 2020 to 2025, Arrivent BioPharma, Inc., as Independent Director from 2022 to 2025, BioCryst Pharmaceuticals, Inc., as Director in 2007, and various other companies.
Dr. Gordon received his doctorate degree in 1993 from Massachusetts Institute of Technology and undergraduate degree in 1987 from Harvard College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2025 5,250 ( 0.03% ) 59 063 $ 31/05/2026
31/03/2026 0 ( -.--% ) - $ 31/05/2026

Carl Gordon active positions

CompaniesPositionStart
COMPASS THERAPEUTICS, INC. Chairman 01/01/2015
Founder 01/01/1989
Director/Board Member -
X4 Pharmaceuticals (Austria) GmbH
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -

Former positions of Carl Gordon

CompaniesPositionEnd
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
See the detail of Carl Gordon's experience

Training of Carl Gordon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

72

1st degree connections

60

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies60

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Finance

Finance

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

X4 Pharmaceuticals (Austria) GmbH

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology